Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
2.370
+0.110 (4.87%)
At close: Nov 4, 2024, 4:00 PM
2.320
-0.050 (-2.11%)
After-hours: Nov 4, 2024, 6:03 PM EST

Company Description

Mangoceuticals, Inc. develops, markets, and sells various men’s wellness products and services through a telemedicine platform in the United States.

It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name.

The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.

Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program.

The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Mangoceuticals, Inc.
Mangoceuticals logo
Country United States
Founded 2021
IPO Date Mar 21, 2023
Industry Health Information Services
Sector Healthcare
Employees 3
CEO Jacob Cohen

Contact Details

Address:
15110 North Dallas Parkway, Suite 600
Dallas, Texas 75248
United States
Phone (214) 242-9619
Website mangoceuticals.com

Stock Details

Ticker Symbol MGRX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $4.00
CIK Code 0001938046
CUSIP Number 56270V106
ISIN Number US56270V1061
Employer ID 87-3841292
SIC Code 8090

Key Executives

Name Position
Jacob D. Cohen Co-Founder, Chief Executive Officer and Chairman
Eugene M. Johnston Chief Financial Officer
Amanda Elizabeth Hammer Chief Operating Officer

Latest SEC Filings

Date Type Title
Oct 31, 2024 8-K Current Report
Oct 25, 2024 8-K Current Report
Oct 22, 2024 8-K Current Report
Oct 21, 2024 8-K Current Report
Oct 11, 2024 8-K Current Report
Oct 3, 2024 8-K Current Report
Oct 2, 2024 8-K Current Report
Oct 1, 2024 8-K Current Report
Sep 27, 2024 8-K Current Report
Sep 5, 2024 EFFECT Notice of Effectiveness